ArticleFrontiers in pharmacology2026

The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study.

Uros Markovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.